Omics Empower, a prominent player in the life sciences sector, has initiated the provision of Xenium™ In Situ Spatial Transcriptomics services from its laboratory at Hong Kong Science Park. This strategic move enhances the capabilities of local research teams and supports groundbreaking advancements in genomics.
Enhancing Research Capabilities
Since opening in July 2025, the Hong Kong facility has focused on delivering state-of-the-art single-cell sequencing and spatial transcriptomics services. By accelerating processing times, the laboratory is able to maintain RNA integrity and cell viability, which are crucial for generating high-quality single-cell data. This commitment to excellence positions Omics Empower as a key contributor to the burgeoning research landscape in the region.
The Power of Xenium™
The Xenium™ platform, developed by 10x Genomics, represents a significant advancement in spatial transcriptomics. It facilitates direct detection and quantification of RNA within intact tissue, all while preserving the intricate architecture of the tissue itself. This technology achieves remarkable single-cell and subcellular resolution, allowing researchers to glean insights that were previously difficult to obtain. As the second laboratory in Hong Kong to adopt the Xenium platform, Omics Empower is poised to meet the growing demand for high-resolution transcriptomics.
A Comprehensive Suite of Technologies
In addition to Xenium™, the Hong Kong laboratory also offers access to the 10x Genomics Visium platform, which specializes in whole-transcriptome spatial profiling. Furthermore, it incorporates Stereo-seq, an innovative technology developed by BGI Group. Together, these platforms provide a diverse range of resolution and tissue-scale options, empowering research teams to select methodologies tailored to their specific study designs and sample characteristics.
Supporting Diverse Research Areas
Omics Empower’s offerings are particularly beneficial across various fields, including oncology, neuroscience, immunology, and translational research. The ability to perform high-resolution in situ spatial transcriptomics opens new avenues for understanding complex biological systems and disease mechanisms. By providing these advanced services locally, Omics Empower strengthens the research infrastructure in Hong Kong and the broader Asia-Pacific region.
Commitment to Regional Growth
With its focus on single-cell and spatial capabilities, Omics Empower is dedicated to expanding its influence in the Asia-Pacific market. The company aims to foster life science and multi-omics research initiatives, facilitating collaboration among researchers and enhancing the quality of scientific outputs. This regional expansion aligns with the global trend of increasing investment in biotechnology and genomics, reflecting the growing recognition of these fields’ importance.
Proven Track Record in the Life Sciences
Omics Empower has established itself as a leader in the global life science service sector, specializing in pioneering technologies such as single-cell sequencing and spatial transcriptomics. With an extensive laboratory network spanning the United States, Europe, and Asia, the company ensures seamless coordination and project delivery for research teams worldwide. Its contributions have been recognized through support for over 500 peer-reviewed publications in distinguished journals, underscoring its commitment to advancing scientific knowledge.
Future Prospects
As Omics Empower continues to innovate and expand its service offerings, it remains at the forefront of the life sciences industry. The launch of Xenium™ In Situ Spatial Transcriptomics services marks a significant milestone in the company’s journey, promising to elevate research capabilities and enhance scientific inquiry in Hong Kong and beyond.
- Key Takeaways:
- Omics Empower launches Xenium™ services in Hong Kong.
- The Xenium™ platform allows for high-resolution RNA detection in tissues.
- A comprehensive suite of technologies is available to support diverse research fields.
- Omics Empower aims to expand its influence in the Asia-Pacific biotech market.
- The company has a robust history of supporting peer-reviewed scientific research.
In conclusion, Omics Empower’s introduction of Xenium™ services in Hong Kong signifies a meaningful advancement in spatial transcriptomics. This initiative not only enhances research capabilities but also positions the company as a vital contributor to the evolving landscape of life sciences in the region. The future holds promising potential as these technologies enable deeper insights into biological complexities, fostering innovation and collaboration across disciplines.
Read more → www.taiwannews.com.tw